Episode
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
- Podcast
- Neurology® Podcast
- Published
- Jul 30, 2026
- Duration seconds
- 1227
- Processing state
not_requested- Canonical source
- https://neurology.libsyn.com/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-2
Actions
POST https://stenobird.com/v1/public/podcasts/neurology-podcast-635512/episodes/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-2/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/neurology-podcast-635512/updates-on-btk-inhibitors-and-multiple-sclerosis-trials-part-2.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting . Read more about the Fenebrutinib Trial . Disclosures can be found at Neurology.org .